Literature DB >> 1988241

Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis.

S Kaojarern1, K Supmonchai, P Phuapradit, C Mokkhavesa, S Krittiyanunt.   

Abstract

Sixteen patients with oral isoniazid, pyrazinamide, rifampin, and intramuscular streptomycin for tuberculous meningitis were studied. The concentrations of isoniazid, pyrazinamide, rifampin, and streptomycin in cerebrospinal fluid (CSF) obtained 3 hours after administration were 2.40, 34.78, 0.29, and 3.78 micrograms/ml, respectively. The CSF concentrations of isoniazid and pyrazinamide were well above the minimum inhibitory concentration for Mycobacterium tuberculosis. Concentrations of rifampin and streptomycin were above the minimal inhibitory concentration initially but declined below the minimal inhibitory concentration at later times. The CSF penetration of isoniazid, pyrazinamide, rifampin, and streptomycin was about 89%, 91%, 5%, and 20%, respectively. In eight patients who received antituberculous drugs in combination with steroids, the mean CSF and serum concentrations, as well as CSF/serum ratios at various intervals of treatment, were not statistically different (p greater than 0.05) from those of the eight patients who did not receive steroids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988241     DOI: 10.1038/clpt.1991.2

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  15 in total

Review 1.  Tuberculous meningitis.

Authors:  G Thwaites; T T Chau; N T Mai; F Drobniewski; K McAdam; J Farrar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

2.  The management of tuberculous meningitis.

Authors:  M Humphries
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 3.  Central nervous system tuberculosis.

Authors:  A Cherian; S V Thomas
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

Review 4.  Tuberculous meningitis.

Authors:  R W Newton
Journal:  Arch Dis Child       Date:  1994-05       Impact factor: 3.791

Review 5.  Tuberculosis of the central nervous system.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

Review 6.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 7.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

Review 8.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.

Authors:  Pranita D Tamma; Alison E Turnbull; Anthony D Harris; Aaron M Milstone; Alice J Hsu; Sara E Cosgrove
Journal:  JAMA Pediatr       Date:  2013-10       Impact factor: 16.193

10.  Tuberculous meningitis: diagnosis and treatment overview.

Authors:  Grace E Marx; Edward D Chan
Journal:  Tuberc Res Treat       Date:  2011-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.